Rockefeller Capital Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Rockefeller Capital Management’s Portfolio CELL Stock Details CELL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-32,307	Closed	-$37K	–	2073
2023 Q1	$37K	Hold	32,307	–	–	﹤0.01%	1932
2022 Q4	$86K	Hold	32,307	–	–	﹤0.01%	2108
2022 Q3	$92K	Hold	32,307	–	–	﹤0.01%	2038
2022 Q2	$160K	Buy	32,307 +32,099	+15,432%	+$168K	﹤0.01%	1715
2022 Q1	$0	Buy	208 +148	+247%	+$1.22K	﹤0.01%	4135
2021 Q4	$1K	Sell	60 -8,990	-99%	-$194K	﹤0.01%	3717
2021 Q3	$177K	Buy	9,050 +4,649	+106%	+$177K	﹤0.01%	1618
2021 Q2	$196K	Buy	4,401 +1,421	+48%	+$65.9K	﹤0.01%	1518
2021 Q1	$149K	Buy	2,980 +726	+32%	+$49.5K	﹤0.01%	1437
2020 Q4	$201K	Hold	2,254	–	–	﹤0.01%	1189
2020 Q3	$172K	Buy	+2,254	New	+$143K	﹤0.01%	1089

Other funds holding CELL

Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return

NIMC

Nierenberg Investment Management Company Camas, Washington $201M AUM 36.3% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Rockefeller Capital Management's CELL Position: Q2 2023 in Review

Rockefeller Capital Management sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2023, closing a stake of 32,307 shares — an estimated $37K sold.

Rockefeller Capital Management first reported a position in CELL in Q3 2020 and held it in 11 quarters. The position peaked at $201K in Q4 2020. 84 funds tracked by Wall St. Rank hold CELL as of Q2 2023.

Rockefeller Capital Management reported no remaining PhenomeX Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Rockefeller Capital Management sold 32,307 PhenomeX Inc. Common Stock shares in Q2 2023, an estimated $37K.
Rockefeller Capital Management first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 11 quarters.
Rockefeller Capital Management's PhenomeX Inc. Common Stock position peaked at $201K in Q4 2020.
84 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2023.

Based on Rockefeller Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.